CELC

Celcuity Inc.

Biotechnology · Biotechnology

$303.62 sample

-3.35 (-1.09%) 1D

Market cap

$196.0B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-28

Alerts

8

Price$303.62 +14.14% 3M daily closessample

309.75261.24

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 07INSInsider sell: EVP, Operations
Sep 28SEC8-K filed: material event
Sep 23INSInsider buy: Chief Executive Officer
Sep 15SECDEF 14A filed
Sep 08INSInsider buy: EVP, Operations
Sep 03INSInsider buy: Chief Executive Officer
Aug 27INSInsider sell: Chief Financial Officer
Aug 19INSInsider sell: Chief Executive Officer

Sign up to see the real CELC record →

Company facts

SEC EDGAR registration

Name: Celcuity Inc.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: +53sample, -100 to +100
Reporting currency: USD

Who is positioning in CELC

sample

Insiders: 9 insider transactions over 90 days, net selling, $631.0M
Congress: 3 members traded over 90 days
Institutions · 13F: 24 funds hold $3.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$10.8B +19.7% y/y

Q4 2024Q3 2026

Inventory$6.3B +7.8% y/y

Q4 2024Q3 2026

Accounts receivable$4.6B +14.1% y/y

Q4 2024Q3 2026

Total debt$12.4B +17.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $94.0B -1.8% 3M
Sample peer B: $85.1B +8.2% 3M
Sample peer C: $37.1B +2.6% 3M
Sample peer D: $51.4B -7.0% 3M
Sample peer E: $105.8B -5.3% 3M